MERTK and neoplasm: Moreover, Niu et al.144engineered a family of CAR‐Ms which target CCR7+ immunosuppressive cell population by CCL19 modification and trigger tumor cell cytotoxicity by the cytosolic domain from Mer receptor tyrosine kinase (MerTK).